ALCOX:EPA
NicOx SA
0,30 €
arrow_downward
-0,66%(-0,0020) 1D
13 հոկ, 17:35:15 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALCOX...
Open
0,30 €
High
0,31 €
Low
0,30 €
Mkt. cap
29,56 մլն
Avg. vol.
159,77 հզր
Volume
100,96 հզր
52-wk high
0,57 €
52-wk low
0,28 €
EPS
-0,03 €
Shares outstanding
97,55 մլն
No. of employees
10
Open
0,30 €
High
0,31 €
Low
0,30 €
Mkt. cap
29,56 մլն
Avg. vol.
159,77 հզր
Volume
100,96 հզր
52-wk high
0,57 €
52-wk low
0,28 €
EPS
-0,03 €
Shares outstanding
97,55 մլն
No. of employees
10
News stories
From web sources and news partners
Seeking Alpha
·
41 րոպե առաջ
Mentions of inflation have ballooned for tech companies – SoFi (SP500:)
Central Oregon Daily
·
32 րոպե առաջ
S&P 500 flat as chipmakers fall and bank earnings roll in
ChartMill
·
55 րոպե առաջ
What's going on in today's session: S&P500 most active stocks
Profile
Nicox S.A. is a French ophthalmology company developing treatments to maintain vision and improve ocular health. Nicox is headquartered in Sophia Antipolis, France, and its Chairman and CEO is Michele Garufi.
Nicox is listed on Euronext Paris and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes. Its pipeline includes three programs in development, and it has two U.S. Food and Drug Administration approved products. Wikipedia
About NicOx SA
CEO-
Employees10
Founded1996
HeadquartersՎալբոն, Պրովանս Ալպեր Լազուր ափ, Ֆրանսիա
Sector-
Websitenicox.com